Literature DB >> 16387805

Superoxide dismutase expression attenuates cigarette smoke- or elastase-generated emphysema in mice.

Robert F Foronjy1, Oleg Mirochnitchenko, Olga Propokenko, Vincent Lemaitre, Yuxia Jia, Masayori Inouye, Yasunori Okada, Jeanine M D'Armiento.   

Abstract

RATIONALE: Oxidants are believed to play a major role in the development of emphysema.
OBJECTIVES: This study aimed to determine if the expression of human copper-zinc superoxide dismutase (CuZnSOD) within the lungs of mice protects against the development of emphysema.
METHODS: Transgenic CuZnSOD and littermate mice were exposed to cigarette smoke (6 h/d, 5 d/wk, for 1 yr) and compared with nonexposed mice. A second group was treated with intratracheal elastase to induce emphysema. MEASUREMENTS: Lung inflammation was measured by cell counts and myeloperoxidase levels. Oxidative damage was assessed by immunofluorescence for 3-nitrotyrosine and 8-hydroxydeoxyguanosine and lipid peroxidation levels. The development of emphysema was determined by measuring the mean linear intercept (Lm). MAIN
RESULTS: Smoke exposure caused a fourfold increase in neutrophilic inflammation and doubled lung myeloperoxidase activity. This inflammatory response did not occur in the smoke-exposed CuZnSOD mice. Similarly, CuZnSOD expression prevented the 58% increase in lung lipid peroxidation products that occurred after smoke exposure. Most important, CuZnSOD prevented the onset of emphysema in both the smoke-induced model (Lm, 68 exposed control vs. 58 exposed transgenic; p < 0.04) and elastase-generated model (Lm, 80 exposed control vs. 63 exposed transgenic; p < 0.03). These results demonstrate for the first time that antioxidants can prevent smoke-induced inflammation and can counteract the proteolytic cascade that leads to emphysema formation in two separate animal models of the disease.
CONCLUSIONS: These findings indicate that strategies aimed at enhancing or supplementing lung antioxidants could be effective for the prevention and treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16387805      PMCID: PMC3982860          DOI: 10.1164/rccm.200506-850OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  69 in total

1.  From the Centers for Disease Control and Prevention. Prevalence of current cigarette smoking among adults and changes in prevalence of current and some day smoking--United States, 1996-2001.

Authors: 
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

2.  Mitogen-activated protein kinases modulate H(2)O(2)-induced apoptosis in primary rat alveolar epithelial cells.

Authors:  Helotonio Carvalho; Pablo Evelson; Samuel Sigaud; Beatriz González-Flecha
Journal:  J Cell Biochem       Date:  2004-06-01       Impact factor: 4.429

3.  Progressive adult-onset emphysema in transgenic mice expressing human MMP-1 in the lung.

Authors:  Robert F Foronjy; Yasunori Okada; Randolph Cole; Jeanine D'Armiento
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-01-10       Impact factor: 5.464

4.  Regulation of LPS-mediated inflammation in vivo and in vitro by the thiol antioxidant Nacystelyn.

Authors:  Frank Antonicelli; David Brown; Maryline Parmentier; Ellen M Drost; Nik Hirani; Irfan Rahman; Ken Donaldson; William MacNee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-06       Impact factor: 5.464

5.  Extracellular regulated kinase/mitogen activated protein kinase is up-regulated in pulmonary emphysema and mediates matrix metalloproteinase-1 induction by cigarette smoke.

Authors:  Becky A Mercer; Natalia Kolesnikova; Joshua Sonett; Jeanine D'Armiento
Journal:  J Biol Chem       Date:  2004-02-05       Impact factor: 5.157

6.  Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice.

Authors:  Steven D Shapiro; Nir M Goldstein; A McGarry Houghton; Dale K Kobayashi; Diane Kelley; Abderazzaq Belaaouaj
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 7.  Prospects for new drugs for chronic obstructive pulmonary disease.

Authors:  Peter J Barnes; Trevor T Hansel
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

Review 8.  Superoxide dismutases in the lung and human lung diseases.

Authors:  Vuokko L Kinnula; James D Crapo
Journal:  Am J Respir Crit Care Med       Date:  2003-06-15       Impact factor: 21.405

9.  Emphysematous changes are caused by degradation of type III collagen in transgenic mice expressing MMP-1.

Authors:  Takayuki Shiomi; Yasunori Okada; Robert Foronjy; John Schiltz; Rudolph Jaenish; Steve Krane; Jeanine D'Armiento
Journal:  Exp Lung Res       Date:  2003 Jan-Feb       Impact factor: 2.459

10.  Elevated urinary 8-hydroxydeoxyguanosine, a biomarker of oxidative stress, and lack of association with antioxidant vitamins in chronic obstructive pulmonary disease.

Authors:  Tadashi Igishi; Yutaka Hitsuda; Kazuhiro Kato; Takanori Sako; Naoto Burioka; Kazuhito Yasuda; Hiroyuki Sano; Yasushi Shigeoka; Hirofumi Nakanishi; Eiji Shimizu
Journal:  Respirology       Date:  2003-12       Impact factor: 6.424

View more
  62 in total

1.  Edible Myrciaria vexator fruits: bioactive phenolics for potential COPD therapy.

Authors:  Keyvan Dastmalchi; Gema Flores; Shi-Biao Wu; Chunhui Ma; Abdoulaye J Dabo; Kathleen Whalen; Kurt A Reynertson; Robert F Foronjy; Jeanine M D Armiento; Edward J Kennelly
Journal:  Bioorg Med Chem       Date:  2012-05-14       Impact factor: 3.641

2.  Antioxidant diet protects against emphysema, but increases mortality in cigarette smoke-exposed mice.

Authors:  Toru Nyunoya; Thomas H March; Yohannes Tesfaigzi; JeanClare Seagrave
Journal:  COPD       Date:  2011-08-11       Impact factor: 2.409

Review 3.  The pharmokinetic limitations of antioxidant treatment for COPD.

Authors:  Robert Foronjy; Alison Wallace; Jeanine D'Armiento
Journal:  Pulm Pharmacol Ther       Date:  2007-10-23       Impact factor: 3.410

4.  Imbalance of apoptosis and cell proliferation contributes to the development and persistence of emphysema.

Authors:  Ji-Hyun Lee; Masayuki Hanaoka; Yoshiaki Kitaguchi; Donatas Kraskauskas; Leland Shapiro; Norbert F Voelkel; Laima Taraseviciene-Stewart
Journal:  Lung       Date:  2011-10-21       Impact factor: 2.584

Review 5.  Emergent structure-function relations in emphysema and asthma.

Authors:  Tilo Winkler; Béla Suki
Journal:  Crit Rev Biomed Eng       Date:  2011

6.  Protein kinase C zeta mediates cigarette smoke/aldehyde- and lipopolysaccharide-induced lung inflammation and histone modifications.

Authors:  Hongwei Yao; Jae-woong Hwang; Jorge Moscat; Maria T Diaz-Meco; Michael Leitges; Nandini Kishore; Xiong Li; Irfan Rahman
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

Review 7.  Animal models of chronic obstructive pulmonary disease.

Authors:  Joanne L Wright; Manuel Cosio; Andrew Churg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

8.  Protein transfection of mouse lung.

Authors:  Patrick Geraghty; Robert Foronjy
Journal:  J Vis Exp       Date:  2013-05-15       Impact factor: 1.355

Review 9.  Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Comparison of two quantitative methods of discerning airspace enlargement in smoke-exposed mice.

Authors:  Richard E Jacob; James P Carson; Kathy M Gideon; Brett G Amidan; Cathie L Smith; K Monica Lee
Journal:  PLoS One       Date:  2009-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.